T Cells co- Expressing a Second Generation Glypican 3-specific Chimeric Antigen Receptor With Cytokines Interleukin-21 and 15 as Immunotherapy for Patients With Liver Cancer (TEGAR)
Learn more about:
Related Clinical Trial
Evaluation of Lung Metastases Based on Ultrashort Echo Time MRI
GastroIntestinal Cancer in Children and Adolescents
Relapsed and Refractory Hepatoblastoma: A Prospective Registry and Liver Tumor Research Consortium Initiative
Sequential PD-1/PD-L1 Inhibitor and LENvatinib in TLCT and Refractory Hepatoblastoma After Chemotherapy
Deep Learning Magnetic Resonance Imaging Radiomics for Diagnostic Value of Hepatic Tumors in Infants
ET140203 T-Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma
Biomarkers in Tissue Samples From Young Patients With Liver Cancer
Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer
Paediatric Hepatic International Tumour Trial
Diagnostic Accuracy of PIVKA-II Combining With Alpha-Fetoprotein in Hepatic Tumor
T Cells co- Expressing a Second Generation Glypican 3-specific Chimeric Antigen Receptor With Cytokines Interleukin-21 and 15 as Immunotherapy for Patients With Liver Cancer (TEGAR)
Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
Hepatoblastoma Biology Study and Tissue Bank
Combined Modality Therapy in Hepatoblastoma: South Egypt Cancer Institute Experience